[Anti-fibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline in lung of rat with silicosis]
- PMID: 19080377
[Anti-fibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline in lung of rat with silicosis]
Abstract
Objective: To investigate the effect of N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) on the collagen synthesis and expression in lung of rats with silicosis.
Methods: Rats were divided into 6 groups randomly, 10 rats in each group: Control 1 of silicotic model: each rat was intratracheally instilled with 1 ml normal sodium and was killed at the fourth week; Control 2 of silicotic model: each rat was intratracheally instilled with 1 ml normal sodium and was killed at the eighth week; Silicotic model 1: each rat was intratracheally instilled with 1 ml silica suspension and was killed at the fourth week; Silicotic model 2: each rat was intratracheally instilled with 1 ml silica suspension and was killed at the eighth week; Anti-fibrosis treatment of AcSDKP: after each rat was intratracheally instilled with 1 ml silica suspension for 4 weeks, AcSDKP 800 microg/(kgxd) was administered into every rat and rats were killed at the eighth week; Preventing fibrosis treatment of AcSDKP: after AcSDKP 800 microg/(kgxd) was administered into every rat for 48 hours, each rat was intratracheally instilled with 1 ml silica suspension and rats were killed at the eighth week. Lung fibrosis in morphology was observed by HE and VG staining. Collagen content was detected by hydroxyproline assay. The expression of type I and III collagen was evaluated by western blot.
Results: Compared with those of silicotic model 1 and silicotic model 2 group, in anti-fibrosis treatment of AcSDKP group, the area of silicosis nodules decreased to 84.28% and 67.93%, the content of hydroxyproline decreased to 70.89% and 58.18%, the expression of type I collagen decreased to 71.08% and 58.13%, and expression of type III collagen decreased to 80.13% and 70.70%. Compared with those of silicotic model 2 group, in preventing fibrosis treatment of AcSDKP group, area of silicosis nodules decreased to 61.13%, content of hydroxyproline decreased to 60.27%, and expression of type I and type III collagen decreased to 40.13% and 65.77%.
Conclusion: AcSDKP could obviously inhibit the synthesis and expression of collagen in lung of rats with silicosis, which is possibly related with anti-fibrosis effect of AcSDKP.
Similar articles
-
[Effect of N-acetyl-seryl-aspartyl-lysyl-proline on regulation of expression of ras-raf-ERK1/2 signal transduction pathway in lung of rats with silicosis].Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2010 Oct;28(10):760-5. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2010. PMID: 21126429 Chinese.
-
[Antifibrotic effects of N-acetyl-seryl-aspartyl-lysyl-proline mediated by the regulation of MCP-1 and ED-1 expression on rats with silicosis].Wei Sheng Yan Jiu. 2008 Nov;37(6):666-70. Wei Sheng Yan Jiu. 2008. PMID: 19238998 Chinese.
-
[Regulating effect of N-acetyl-seryl-aspartyl-lysyl-proline on activation of c-jun N-terminal kinase pathway in rats with silicosis].Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2013 May;31(5):335-40. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2013. PMID: 23803521 Chinese.
-
N-acetyl-seryl-aspartyl-lysyl-proline is a valuable endogenous antifibrotic peptide for kidney fibrosis in diabetes: An update and translational aspects.J Diabetes Investig. 2020 May;11(3):516-526. doi: 10.1111/jdi.13219. Epub 2020 Mar 11. J Diabetes Investig. 2020. PMID: 31997585 Free PMC article. Review.
-
Silica and asbestos: contrasts in tissue response.Ann N Y Acad Sci. 1979;330:725-44. doi: 10.1111/j.1749-6632.1979.tb18777.x. Ann N Y Acad Sci. 1979. PMID: 230775 Review. No abstract available.
Cited by
-
A new antifibrotic target of Ac-SDKP: inhibition of myofibroblast differentiation in rat lung with silicosis.PLoS One. 2012;7(7):e40301. doi: 10.1371/journal.pone.0040301. Epub 2012 Jul 3. PLoS One. 2012. PMID: 22802960 Free PMC article.
-
Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis.Oncotarget. 2016 Jun 7;7(23):33841-54. doi: 10.18632/oncotarget.8409. Oncotarget. 2016. PMID: 27029074 Free PMC article.
-
The Role of Tβ4-POP-Ac-SDKP Axis in Organ Fibrosis.Int J Mol Sci. 2022 Oct 31;23(21):13282. doi: 10.3390/ijms232113282. Int J Mol Sci. 2022. PMID: 36362069 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical